country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-P990691

Copy Link Print Information

Biologically Validated

Vilamakitug

Name: Vilamakitug
Brand: MedChemExpress
SKU: HY-P990691
Price: 280.00 USD
Availability: InStock
Rating: 5 (1 reviews)

(Synonyms: XB-2001)

Kundenbewertung

Based on 1 Customer Validation

Vilamakitug (XB-2001) is an anti-IL-1α monoclonal antibody that blocks IL-1α signaling. Vilamakitug binds to and neutralizes IL-1α. Vilamakitug can be used for research on metastatic colorectal cancer and melanoma.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Reinheit : 95.45%
CAS. Nr.: 2458202-06-5
Molecular Weight:145.971 kDa

Speicherung:

Shipping with dry ice

Please store the product under the recommended conditions in the Certificate of Analysis.

Vilamakitug Chemical Structure

CAS. Nr.: 2458202-06-5

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- Isotype
- Recommend Isotype Controls
- Species Reactivity
- IC₅₀ & Target
- In Vivo
- Clinical Trial
- Gene ID
- Accession
- Conjugated
- Reconstitution
- Format
- Anwendung
- Verified Bioactivity
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

Isotype

Human IgG4 kappa

Recommend Isotype Controls

Human IgG4 (S228P) kappa, Isotype Control

Species Reactivity

Human

IC₅₀ & Target

^[1]^[2]

IL-1α

Alle Interleukin Related Isoform-spezifische Produkte anzeigen :

In Vivo

Anti-cancerCytokines & ChemokinesImmune Tolerance & ImmunosuppressionLocal Vascular Regulation

Anti-cancer

Cytokines & Chemokines

Immune Tolerance & Immunosuppression

Local Vascular Regulation

Vilamakitug (0.1-2.0 mg; i.p.; every 3 days; five doses) reduces pulmonary melanoma nodule burden, lung tumor area, and melanoma-associated biomarker expression in B16-F10 pulmonary metastasis^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Clinical Trial

NCT Number	Sponsor	Condition	Start Date	Phase A549
NCT01329991			2011-05	PHASE1

Gene ID

3552 [NCBI]

Accession

P01583

Conjugated

Unconjugated

Reconstitution

The product can be reconstituted/diluted with sterile PBS or saline.

Format

IgG4-kappa

Anwendung

ELISA, FACS, Functional assay

Verified Bioactivity

Immobilized IL-1 alpha Protein, Human (HY-P7027) can bind Vilamakitug. The EC₅₀ for this effect is 19.95 ng/mL.

Chemical Information

CAS. Nr. 2458202-06-5
Appearance Liquid
Molecular Weight 145.971 kDa
Color Colorless to light yellow
Synonyms

XB-2001
Versand

Shipping with dry ice.
Formulation

Please refer to the lot-specific COA for specific buffer information.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (259 KB)
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Inhibitory Antibodies User Guide (603 KB)

Verweise

[1]. Mei HR, et al. The therapeutic potential of targeting IL-1α signaling pathways in a mouse model of pulmonary melanoma. Sci Rep. 2026;16(1):13452.

[2]. Thibaudin M, et al. Safety and efficacy of trifluridine/tipiracil +/- bevacizumab plus XB2001 (anti-IL-1α antibody): a single-center phase 1 trial. Signal transduction and targeted therapy. 2025 Jan 17;10(1):22.

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen

Amount: USD 0.00

Biologische Aktivität
- Beschreibung
- Isotype
- Recommend Isotype Controls
- Species Reactivity
- IC₅₀ & Target
- In Vivo
- Clinical Trial
- Gene ID
- Accession
- Conjugated
- Reconstitution
- Format
- Anwendung
- Biological Activity
Chemical Information
Reinheit & Dokumentation
Verweise

Produktname:
Art. -Nr.:
Menge:
MCE Japan Authorized Agent:

Produktname:
CAS. Nr.:
Species:
Reinheit:
Menge:

Vilamakitug

Alle Interleukin Related Isoform-spezifische Produkte anzeigen